# FDA Inspection 805212 - Novacyl - October 25, 2012

Source: https://www.keypedia.com/records/fda_inspections/novacyl/ee621f50-5004-41ff-bf1c-ab5ea4f234fe
Source feed: FDA_Inspections

> FDA Inspection 805212 for Novacyl on October 25, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 805212
- Company Name: Novacyl
- Inspection Date: 2012-10-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1245783 - 2023-11-24](https://www.keypedia.com/records/fda_inspections/novacyl/aa76905a-c63f-4b6e-a37b-0a8e803f7661)
- [FDA Inspection 1245783 - 2023-11-24](https://www.keypedia.com/records/fda_inspections/novacyl/6d3ea747-fb43-42ec-b7b2-28ed9d6ca318)

Company: https://www.keypedia.com/companies/novacyl/928b015a-ee45-4383-ad21-070b43308727

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c